This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Jens Mattow: Innovator in Immunization and Diagnostics
Introduction
Jens Mattow is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of immunization and diagnostics through his innovative research and patents. His work focuses on the identification of specific differentially expressed antigens, which are crucial for developing effective vaccines and diagnostic tools.
Latest Patents
Jens Mattow holds a patent titled "Identification of specific differentially expressed antigens." This invention relates to compositions that are useful in immunization against pathogenic organisms and for diagnostic purposes. The patent describes a composition comprising at least one protein that is differentially expressed in a virulent strain compared to an avirulent strain. Additionally, it includes fusion proteins, antigenic fragments, nucleic acid molecules encoding these proteins, and antibodies. The invention also encompasses pharmaceutical and diagnostic compositions that utilize these compounds for treating induced diseases and preparing vaccines.
Career Highlights
Jens Mattow is affiliated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its cutting-edge scientific research. His work has contributed to advancements in immunology and has the potential to impact public health positively.
Collaborations
Throughout his career, Jens has collaborated with notable colleagues, including Peter Jungblut and Hans Mollenkopf. These collaborations have fostered a productive research environment, leading to innovative solutions in the field of immunization.
Conclusion
Jens Mattow's contributions to immunization and diagnostics through his patent and research at the Max Planck Society highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and disease treatment.